Nuclear Medicine: Page 209

Positron seeks to bolster cardiac PET's rubidium-82 supply

By Brian Casey

PET developer Positron has labored literally for decades to make cardiac PET a clinical reality. The company's effort was paying off until late last year, when the market got sidetracked by a disruption in the supply of rubidium-82. Positron's solution? Grow your own.

February 1, 2012

Florbetapir PET detects rising beta amyloid in healthy adults

By Wayne Forrest

Researchers have found that florbetapir PET detects high levels of beta amyloid in the cortical regions of brains of cognitively normal adults -- levels that were linked to a higher risk of Alzheimer's disease and decreasing mental performance, according to a study published online February 1 in Neurology.

January 31, 2012

PET market rebounds; do radiologists self-refer?

By Brian Casey

January 30, 2012

Group urges import ban on Russian Mo-99

By AuntMinnie.com staff writers

A coalition of U.S. public health, medical, and nuclear nonproliferation groups is urging Congress to restrict the use of imported molybdenum-99 (Mo-99) from Russia, which uses bomb-grade uranium to produce the radioisotope.

January 30, 2012

PET sales reverse downward trend, could hit $1.7B in 2018

By Wayne Forrest

Reversing a five-year decline, sales of PET scanners rose in 2010 in the U.S., although the modality continued to struggle internationally. Better things are on the horizon, however, as worldwide PET sales are expected to hit $1.7 billion by 2018, according to a new market research report.

January 30, 2012

GE installs 1st MBI system in U.S.

By AuntMinnie.com staff writers

GE Healthcare has installed its Discovery NM 750b molecular breast imaging (MBI) system at Capital Health Medical Center - Hopewell in Pennington, NJ.

January 29, 2012

JACC: Questions remain about cardiac radiation's link to cancer

By Eric Barnes

There are still no strong data linking the use of ionizing radiation in cardiac imaging to the development of cancer, though several studies have found that higher radiation exposure may increase the risk of developing cancer, concludes a paper published online January 30 in the Journal of the American College of Cardiology.

January 29, 2012

Manhattan Isotope gets strontium-82 license

By AuntMinnie.com staff writers

Manhattan Isotope Technology has received approval of its radioactive materials license amendment from the radiation control program at the Texas Department of State Health Services.

January 29, 2012

PET/CT detects head/neck cancer recurrences earlier

By Cynthia E. Keen

Routine use of follow-up PET/CT scans can detect local cancer recurrences before they become clinically apparent, and may improve outcomes of subsequent salvage therapy, according to a study presented on Friday at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.

January 27, 2012

Shine Medical picks Mo-99 plant site in Wis.

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has unveiled plans to build a new molybdenum-99 (Mo-99) manufacturing plant in Janesville, WI.

January 24, 2012

Cell>Point inks Brazilian license deal

By AuntMinnie.com staff writers

Radiopharmaceutical developer Cell>Point has signed a long-term collaboration agreement including product licenses for Brazil with MJM Produtos Farmacêuticos e de Radioproteção (Radiopharmacus).

January 24, 2012

BSGI equals MRI as an adjunct in breast cancer cases

By Wayne Forrest

Researchers in Oregon have concluded that breast-specific gamma imaging (BSGI) is equivalent to MRI as an adjunct imaging modality for diagnosing breast cancer. BSGI may be particularly useful in evaluating women at high risk for cancer, or those with dense breasts.

January 24, 2012

Previous Page

Page 209 of 440

Next Page